Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E32.13 EPS (ttm)2.52 Insider Own0.20% Shs Outstand733.91M Perf Week-2.30%
Market Cap59.42B Forward P/E14.84 EPS next Y5.46 Insider Trans-2.46% Shs Float732.25M Perf Month1.89%
Income1.94B PEG2.34 EPS next Q1.38 Inst Own86.70% Short Float2.56% Perf Quarter11.19%
Sales100.36B P/S0.59 EPS this Y28.30% Inst Trans-2.83% Short Ratio4.91 Perf Half Y17.95%
Book/sh27.31 P/B2.96 EPS next Y11.82% ROA3.60% Target Price82.86 Perf Year19.27%
Cash/sh1.14 P/C71.18 EPS next 5Y13.73% ROE9.10% 52W Range64.64 - 85.72 Perf YTD15.28%
Dividend- P/FCF14.58 EPS past 5Y8.40% ROI6.80% 52W High-5.54% Beta1.17
Dividend %- Quick Ratio0.50 Sales past 5Y36.50% Gross Margin7.90% 52W Low25.26% ATR1.29
Employees29975 Current Ratio0.60 Sales Q/Q-0.50% Oper. Margin3.50% RSI (14)50.38 Volatility1.98% 1.41%
OptionableYes Debt/Eq0.73 EPS Q/Q44.40% Profit Margin1.90% Rel Volume2.57 Prev Close80.48
ShortableYes LT Debt/Eq0.57 EarningsOct 28 AMC Payout0.00% Avg Volume3.81M Price80.97
Recom2.00 SMA20-2.05% SMA503.82% SMA20010.73% Volume9,796,472 Change0.61%
Dec-16-14Reiterated Oppenheimer Outperform $82 → $88
Dec-15-14Reiterated UBS Buy $82 → $96
Dec-04-14Reiterated Deutsche Bank Hold $76 → $88
Dec-03-14Reiterated Barclays Overweight $83 → $94
Oct-30-14Reiterated RBC Capital Mkts Outperform $73 → $82
Jul-30-14Reiterated FBR Capital Outperform $79 → $74
Jul-28-14Reiterated UBS Buy $90 → $82
May-01-14Reiterated Maxim Group Buy $92 → $90
Apr-30-14Reiterated Mizuho Buy $86 → $82
Mar-06-14Reiterated Deutsche Bank Hold $75 → $79
Mar-05-14Reiterated RBC Capital Mkts Outperform $72 → $84
Mar-05-14Initiated Barclays Overweight $85
Feb-21-14Reiterated FBR Capital Outperform $75 → $83
Feb-19-14Reiterated Maxim Group Buy $80 → $92
Feb-18-14Downgrade Monness Crespi & Hardt Buy → Neutral
Jan-17-14Reiterated Mizuho Buy $74 → $86
Nov-21-13Initiated Deutsche Bank Hold $73
Oct-24-13Initiated FBR Capital Outperform $75
Jul-31-13Reiterated Oppenheimer Outperform $65 → $74
Jul-05-13Reiterated Mizuho Buy $63 → $69
Dec-19-14 10:35PM  Riding With the Bull in 2014 at Barrons.com
Dec-16-14 03:41PM  CFO Moves: Express Scripts Holding, RadioShack, LogMeIn, Villeroy & Boch at The Wall Street Journal
03:25PM  [video]Express Scripts Chief Financial Officer Steps Down at TheStreet
07:48AM  Express Scripts Chief Financial Officer Cathy Smith to leave AP
Dec-15-14 06:28PM  Express Scripts CFO Leaves After 11 Months at Bloomberg
05:46PM  After-hours buzz: Coca-Cola, Verifone & more at CNBC
05:06PM  Express Scripts Names New CFO at The Wall Street Journal
04:41PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, EDGAR Online
04:30PM  Express Scripts Initiates Chief Financial Officer Transition Process; Increases Authorization of Share Repurchase Program; and Reaffirms 2014 Guidance PR Newswire
Dec-14-14 08:30AM  5 Trade Ideas for Monday: Alexion Pharmaceutical, Express Scripts, Eaton, 3M and PVH Yahoo Finance Blogs
Dec-12-14 12:00AM  The Cost And Value Of Drugs Part Two: Benefits And Effectiveness at Forbes
Dec-11-14 08:10PM  The Big Business of Selling Prescription-Drug Records at BusinessWeek
05:38PM  How Can Drugmakers Handle New Pricing Pressures? at Investor's Business Daily
01:30PM  Allscripts Deploys eAuth ePA Solution, Boosts EHR Portfolio Zacks
Dec-10-14 06:09PM  Final Glance: Drug Benefits companies AP
06:02PM  Walgreen CEO to leave after Alliance Boots deal in reversal of plan at Fortune
01:19PM  Midday Glance: Drug Benefits companies AP
10:41AM  Early Glance: Drug Benefits companies AP
08:01AM  Allscripts and Express Scripts Collaborate to Deploy Allscripts eAuth Electronic Prior Authorization Solution GlobeNewswire
12:00AM  They Know You Buy Viagra and They Want to Sell You More Bloomberg
Dec-09-14 06:13PM  Large Cap All-Time Highs... Yahoo Finance Blogs
07:00AM  Many Americans on Long-Term Painkillers Take Potentially Fatal Drug Combinations PR Newswire
Dec-08-14 10:38AM  Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI Gurufocus
Dec-01-14 03:51PM  Apple down, Nasdaq down CNBC
Nov-26-14 03:29PM  The Battle Over Drug Prices: Who's on the Front Lines? at Bloomberg
Nov-25-14 01:05PM  More Medicine Goes Off Limits in Drug-Price Showdown Bloomberg
08:00AM  Berkshire Hathaway slightly raises stake in IBM Market Realist
05:00AM  More Medicine Goes Off Limits in Drug-Price Showdown at Bloomberg
Nov-24-14 02:25PM  Express Scripts is Berkshire Hathaways only new 3Q position Market Realist
10:25AM  An overview of Berkshire Hathaways 3Q positions Market Realist
Nov-20-14 04:59PM  Self-critical, Cramer reveals big stock regret at CNBC
Nov-19-14 07:00PM  Jim Cramer's 'Mad Money' Recap: How You Can Profit From My Mistakes at TheStreet
06:00PM  Cramer: Don't let skepticism run away with you CNBC
05:01PM  Consumer stocks take the lead Today... Yahoo Finance Blogs
Nov-18-14 05:57PM  Drug Compounders Sue Express Scripts Over Rejected Claims at Bloomberg
Nov-17-14 07:14AM  Breakout trades all over the place optionMONSTER
05:45AM  Option Traders Bet on These Stocks to Break Out to New Highs at TheStreet
Nov-14-14 05:21PM  Berkshire invests in Express Scripts, makes confidential disclosure Reuters
05:21PM  Warren Buffetts Berkshire Hathaway adds Express Scripts, dumps Deere at Fortune
04:38PM  Warren Buffett and CIOs Buy DirecTV, Charter Communications, General Motors Co, Express ... Gurufocus
04:47AM  Express Scripts draws bullish play optionMONSTER
Nov-12-14 04:59PM  Get Ideas For Stock Buys, Sells In Mutual Fund Monthly Reports Investor's Business Daily
Nov-06-14 12:05PM  3 Stocks Pushing The Health Services Industry Higher at TheStreet
Nov-05-14 10:23AM  Express Scripts to Present at the Credit Suisse Healthcare Conference PR Newswire
Nov-04-14 01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials EDGAR Online Financials
Nov-02-14 10:33AM  Express Scripts (ESRX) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
Oct-31-14 07:00AM  Express Scripts Well Positioned for New Health-Care Order Morningstar
Oct-29-14 02:15PM  Express Scripts Reports In-Line Q3 Earnings, Narrows View Zacks
01:59PM  Express Scripts says AbbVie drug could displace Sovaldi on formulary Reuters
12:00PM  Stocks Flat Ahead of Fed Morningstar
08:30AM  Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today CCBN
08:16AM  Early Movers: HSY, FB, GRMN, WLP, EA, DAL & more at CNBC
Oct-28-14 07:50PM  [$$] Express Scripts Profit Rise at The Wall Street Journal
06:59PM  Express Scripts meets 3Q profit forecasts AP
05:00PM  After-hours buzz: Express Scripts, Facebook & more at CNBC
04:23PM  Earnings roundup: FB, EA, GILD, INVN & ESRX CNBC
04:09PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
04:01PM  Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point PR Newswire
01:04PM  3 Health Services Stocks Pushing The Industry Higher at TheStreet
09:33AM  Sanofi Stuns Investors as U.S. Price Pressure Bites at The Wall Street Journal
07:07AM  Q3 2014 Express Scripts Holding Co Earnings Release - After Market Close CCBN
Oct-27-14 12:50PM  Will DENTSPLY (XRAY) Disappoint Earnings this Season? Zacks
12:32PM  Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? Zacks
06:50AM  Why Earnings Season Could Be Great for Express Scripts (ESRX) Zacks
Oct-23-14 04:01PM  AmerisourceBergen's Move To Go Big Is The Right Rx at Investor's Business Daily
Oct-21-14 11:15AM  Time for a Checkup With This Health Care ETF ETF Trends
Oct-20-14 04:37PM  Will High Price Hurt Gilead Sciences' New Hep-C Drug? at Barrons.com
Oct-16-14 04:56PM  9 pro stock picks for intrepid bulls at CNBC
03:35PM  Buy these stocks now CNBC
Oct-15-14 08:52PM  F.D.A. Approves First 2 Drugs for Treatment of a Fatal Lung Disease at New York Times
07:30AM  2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality and Performance Rating PR Newswire
Oct-10-14 04:32PM  U.S. FDA approves Gilead's $94,500 hepatitis C drug Reuters
02:45PM  Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. Approval at New York Times
Oct-09-14 04:00PM  Express Scripts Holding Company Announces Third Quarter 2014 Earnings Conference Call GlobeNewswire
Oct-08-14 07:30AM  New Express Scripts Analysis Reveals Trends Among Health Exchange Members PR Newswire
Oct-07-14 08:46PM  Health Law Drug Plans Are Given a Check-Up at New York Times
05:35PM  These 3 Upcoming IPOs Have Strong Investor Interest at Investor's Business Daily
04:05PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Oct-06-14 02:15PM  IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs at Investor's Business Daily
01:03PM  3 Stocks Dragging The Health Services Industry Downward at TheStreet
10:38AM  2 Mutual Funds Holding Hospital Stocks Benzinga
Oct-01-14 05:02PM  Mixed Economic Data, Ebola Scares Rattle Markets Benzinga
01:14PM  Walgreen to sell drugs under Express Scripts 2015 Medicare plans Reuters
08:35AM  Express Scripts 2015 Medicare drug plans to be available at Walgreen Reuters
07:30AM  Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network PR Newswire
Sep-30-14 10:01AM  As Walgreen Goes Global, U.S. Medicare Pressures Remain at Forbes
Sep-26-14 01:04PM  3 Stocks Pushing The Health Services Industry Lower at TheStreet
Sep-13-14 12:01AM  $250 Billion in Biotech Drug Savings on Brink of Arrival at Bloomberg
Sep-12-14 04:33PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:27PM  Express Scripts Elects Roderick Palmore to Board of Directors PR Newswire
Sep-11-14 10:48AM  [video] Live Nation Initiated a Buy, Bearish Calls for Macy's at TheStreet
09:29AM  UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company Benzinga
08:27AM  Analysts' Actions: Express Scripts, JDS Uniphase, Omnicare and More TheStreet
08:19AM  How Will This Analyst Downgrade Affect Express Scripts (ESRX) Stock Today? at TheStreet
08:10AM  Top Analyst Upgrades and Downgrades: JDSU, JD.com, Palo Alto, Petrobras, SeaWorld, Twitter, Yandex and More at 24/7 Wall St.
Sep-10-14 08:30PM  Stock Trading Ideas for 9/10/12 Yahoo Finance Blogs
Sep-02-14 01:03PM  WLP, UNH And ESRX, Pushing Health Services Industry Downward at TheStreet
Aug-28-14 01:04PM  3 Stocks Pulling The Health Services Industry Downward at TheStreet
Aug-23-14 12:01AM  Writing a Bigger Book at Barrons.com
Aug-21-14 06:00AM  Ferguson Shows U.S. Impulse to Kill Cities in Search for Growth at Bloomberg
Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. It operates in two segments, PBM and Other Business Operations. The company's PBM services comprise retail network pharmacy administration; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management; clinical solutions to improve health outcomes; an array of Medicare Part D, Medicaid, and health insurance marketplace; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio- pharmaceutical services, including reimbursement and logistics solutions; group purchasing organization administration; and consumer health and drug information services. It is also involved in the distribution of pharmaceuticals and medical supplies to providers and clinics; development of scientific evidence to guide the use of medicines; and provision of case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. Express Scripts Holding Company provides its PBM services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, and government health programs; and specialty services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ebling Keith J.Exec. VP and General CounselDec 02Sale84.2510,000842,5000Dec 03 04:04 PM
Miller Steven BSr. VP & Chief Med. OfficerDec 01Sale83.574,896409,14416,521Dec 03 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Option Exercise47.6110,800514,18830,657Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Sale82.9610,800895,94619,857Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Option Exercise47.6110,874517,71130,731Nov 25 04:38 PM
MAC MAHON THOMAS PDirectorNov 21Option Exercise35.8512,694455,01654,066Nov 25 04:40 PM
MAC MAHON THOMAS PDirectorNov 21Sale80.9312,6941,027,35141,372Nov 25 04:40 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Sale81.5010,874886,23119,857Nov 25 04:38 PM
PARKER JOHN ODirectorNov 17Option Exercise33.3025,822859,75365,503Nov 18 05:04 PM
PARKER JOHN ODirectorNov 17Sale78.7525,8222,033,43139,681Nov 18 05:04 PM
Breen Maura CDirectorNov 07Option Exercise30.8313,128404,73630,438Nov 10 04:16 PM
Breen Maura CDirectorNov 07Sale77.8013,1281,021,34517,310Nov 10 04:16 PM
IGNACZAK EDWARD BEVPSep 05Sale75.289,886744,21675,996Sep 09 05:01 PM
STERNBERG SEYMOURDirectorAug 28Option Exercise54.3015,508842,07920,277Sep 02 04:07 PM
STERNBERG SEYMOURDirectorAug 28Sale74.1215,5081,149,3914,769Sep 02 04:07 PM
Ebling Keith J.Exec. VP and General CounselAug 25Sale75.5010,000755,00010,000Aug 26 04:04 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Option Exercise53.0520,0001,061,00049,532Aug 06 04:10 PM
BENANAV GARY GDirectorAug 05Option Exercise35.8512,694455,01655,705Aug 07 04:08 PM
BENANAV GARY GDirectorAug 05Sale70.8212,694898,98943,011Aug 07 04:08 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Sale70.4420,0001,408,80029,532Aug 06 04:10 PM
Norton David ASenior VP, Supply ChainAug 04Sale71.021,27690,6270Aug 06 04:13 PM
Breen Maura CDirectorAug 01Option Exercise35.8512,694455,01630,283Aug 05 04:55 PM
Breen Maura CDirectorAug 01Sale69.9412,694887,75517,589Aug 05 04:55 PM
PAZ GEORGEChairman & CEOJun 13Option Exercise26.68681,50818,179,3841,469,761Jun 17 05:04 PM
PAZ GEORGEChairman & CEOJun 13Sale71.21681,50848,530,185788,253Jun 17 05:04 PM
WENTWORTH TIMOTHY CPresidentMay 27Option Exercise47.25127,1896,009,516228,492May 29 05:03 PM
WENTWORTH TIMOTHY CPresidentMay 27Sale70.47105,6777,447,058122,815May 29 05:03 PM
Wimberly GarySr. VP & Ch. Information Off.Mar 13Option Exercise45.3934,5361,567,69758,157Mar 17 04:34 PM
Wimberly GarySr. VP & Ch. Information Off.Mar 13Sale78.4144,4973,489,09913,660Mar 17 04:34 PM
Houston ChristineSr. Vice President, OperationsMar 12Option Exercise31.9215,674500,31438,071Mar 14 06:24 PM
Houston ChristineSr. Vice President, OperationsMar 12Sale78.5319,7571,551,45818,314Mar 14 06:24 PM
IGNACZAK EDWARD BExec. VP, Sales and MktgMar 11Option Exercise55.14120,2476,630,559206,129Mar 13 05:42 PM
IGNACZAK EDWARD BExec. VP, Sales and MktgMar 11Sale78.54120,2479,443,83985,882Mar 13 05:42 PM
Norton David ASenior VP, Supply ChainMar 11Sale79.153,160250,123630Mar 13 05:38 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 11Sale79.009,582756,97820,000Mar 11 06:02 PM
Miller Steven BSr. VP & Chief Med. OfficerMar 10Sale77.9612,664987,29821,417Mar 12 06:05 PM
McNamee PatrickExec. VP and COOMar 10Sale78.2227,9812,188,5627,664Mar 12 06:03 PM
McNamee PatrickExec. VP and COOMar 10Sale78.3240,4443,167,69512,421Mar 12 06:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 07Option Exercise47.1437,4311,764,58363,624Mar 11 06:04 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Option Exercise49.509,901490,05038,361Mar 11 06:02 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Sale78.5016,1391,266,92822,222Mar 11 06:02 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 07Sale78.2243,7673,423,23919,857Mar 11 06:04 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Sale77.6737,6612,925,17829,582Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 06Option Exercise49.5036,8091,821,86165,269Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 06Sale78.5036,8092,889,54328,460Mar 07 06:44 PM
STERNBERG SEYMOURDirectorMar 05Option Exercise30.8313,128404,73616,406Mar 07 06:56 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Option Exercise23.81139,8623,329,652198,241Mar 07 06:44 PM
STERNBERG SEYMOURDirectorMar 05Sale76.5013,1281,004,3053,278Mar 07 06:56 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Sale77.0051,1163,935,9320Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Sale77.03169,78113,078,06128,460Mar 07 06:44 PM
ROPER WILLIAM LDirectorFeb 25Option Exercise39.0341,4961,619,56051,894Feb 27 05:14 PM
ROPER WILLIAM LDirectorFeb 25Sale74.0841,4963,073,81610,398Feb 27 05:14 PM
Houston ChristineSr. Vice President, OperationsFeb 21Option Exercise19.668,948175,93621,177Feb 25 04:46 PM